Next Article in Journal
Long-Lasting Enhanced Cytokine Responses Following SARS-CoV-2 BNT162b2 mRNA Vaccination
Previous Article in Journal
Immunogenicity of the Monovalent Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine against XBB.1.5, BA.2.86, and JN.1 Sublineages: A Phase 2/3 Trial
 
 
Article

Article Versions Notes

Vaccines 2024, 12(7), 735; https://doi.org/10.3390/vaccines12070735
Action Date Notes Link
article xml file uploaded 2 July 2024 13:42 CEST Original file -
article xml uploaded. 2 July 2024 13:42 CEST Update https://www.mdpi.com/2076-393X/12/7/735/xml
article pdf uploaded. 2 July 2024 13:42 CEST Version of Record https://www.mdpi.com/2076-393X/12/7/735/pdf
article supplementary file uploaded. 2 July 2024 13:42 CEST - https://www.mdpi.com/2076-393X/12/7/735#supplementary
article html file updated 2 July 2024 13:45 CEST Original file https://www.mdpi.com/2076-393X/12/7/735/html
Back to TopTop